文献速递心脏核医学骨显像与常规 SPECT

早期99mTc-DPD全身显像及定量SPECT/CT诊断心脏ATTR淀粉样变

Early timepoint 99mTc-DPD whole body scintigraphy and quantitative SPECT/CT imaging for diagnosis of cardiac ATTR amyloidosis.
PubMed 文献 · EJNMMI Res · 2026-06-12

本研究纳入50例疑似心脏转甲状腺素蛋白淀粉样变(ATTR-CM)患者,对比注射99mTc-DPD后1小时早期显像与2.5-3小时标准延迟显像的诊断效能,并采用外部验证队列验证。早期显像视觉评分敏感性、特异性及总诊断准确率与延迟显像相当,HMR与SUVmax定量分析诊断准确率更高,且未出现假阴性。早期显像可提升患者舒适度与检查效率。

要点

  • 早期(1小时)99mTc-DPD显像视觉诊断效能与标准延迟显像相当,无假阴性。
  • 早期显像HMR与SUVmax定量分析诊断准确率高于延迟显像。
  • 早期显像Perugini评分观察者间一致性略低于延迟显像。

核心结论

  • 早期99mTc-DPD显像诊断效能与常规延迟显像等效,并可改善患者舒适度与工作流程效率。
  • 结合定量与半定量分析可优化ATTR-CM诊断流程,促进及时诊断与治疗。

研究设计与样本

  • 单中心研究纳入50例疑似ATTR-CM并接受99mTc-DPD显像及SPECT的患者。
  • 于注射后1小时和2.5-3小时两个时间点分别进行显像。
  • 采用视觉(Perugini评分)、半定量(如HMR)和定量(如SUVmax)方法评估示踪剂摄取。
  • 研究结果在外部验证队列中进行验证。

主要发现

  • 28%的患者诊断为ATTR-CM。
  • 早期显像中位视觉Perugini评分显著高于延迟显像(0.5 vs. 0,p < 0.001)。
  • 早期与延迟显像的组内相关系数非常好。
  • 早期显像视觉评估的敏感性、特异性及总诊断准确率与延迟显像相当,未观察到假阴性结果。
  • 早期显像的HMR和SUVmax诊断准确率更高;早期显像Perugini评分的观察者间一致性低于延迟显像。

关键数值与推荐

  • 视觉评估采用Perugini评分。
  • 半定量评估采用心纵隔比(HMR),定量评估采用最大标准化摄取值(SUVmax)。

临床怎么用

  • 可考虑采用注射后1小时早期99mTc-DPD显像方案诊断ATTR-CM,以提升患者舒适度与检查效率。
  • 建议在视觉评估基础上结合HMR与SUVmax定量分析以提高诊断准确率。
  • 早期显像Perugini评分观察者间一致性略低,判读时需注意。

局限性

  • 早期显像Perugini评分的观察者间一致性低于延迟显像,可能影响视觉判读的可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac transthyretin amyloidosis (ATTR-CM) is a progressive myocardial disease ultimately leading to heart failure. Standard diagnostic workup includes 99mTc-DPD scintigraphy performed after 2.5-3 h. The purpose of this study is to compare early (1 h after injection) to late imaging of 99mTc-DPD scintigraphy and SPECT for the detection of ATTR-CM. Early imaging could improve patient comfort and examination efficiency. RESULTS: 50 patients undergoing 99mTc-DPD scintigraphy and SPECT for suspected ATTR-CM were included. Imaging was performed at both 1 h and 2.5-3 h post-injection. Tracer uptake was assessed visually (Perugini score), semi-quantitatively (e.g., heart-to-mediastinum ratio, HMR), and quantitatively (e.g., maximum standardized uptake value, SUVmax). ATTR-CM was diagnosed in 28% of patients. Median visual Perugini score was significantly higher for early imaging (0.5 vs. 0, p < 0.001). Findings were validated using an external validation cohort. Intraclass correlation coefficients between early and late imaging were very good. Visual evaluation of early imaging demonstrated comparable sensitivity, specificity, and overall diagnostic accuracy to late imaging. HMR and SUVmax from early imaging showed higher diagnostic accuracy. No false-negative results were observed. Visual evaluation using the Perugini score was slightly less consistent between readers in early compared to late imaging, with lower inter-observer agreement at 1 h. CONCLUSIONS: Early 99mTc-DPD imaging provides diagnostic performance equivalent to conventional late imaging while substantially enhancing patient comfort and workflow efficiency. Adoption of early imaging protocols, complemented by quantitative and semi-quantitative analysis, may streamline ATTR-CM diagnostics, enabling timely diagnosis and treatment.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Settelmeier S, Kessler L, Hammersen N, et al. Early timepoint 99mTc-DPD whole body scintigraphy and quantitative SPECT/CT imaging for diagnosis of cardiac ATTR amyloidosis. EJNMMI Res. 2026. PMID: 42286391. doi:10.1186/s13550-026-01466-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。